Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlled Clinical Trial

Clinical trial NCT02744703 · COMPLETED

Trial details

NCT number: NCT02744703
Sponsor: Ege University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Matrix Metalloproteinase Inhibitors Composite Resins

Start date: 2013-04-01
Primary completion: 2015-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.